Literature DB >> 16740596

Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.

Ryozo Kuwano1, Akinori Miyashita, Hiroyuki Arai, Takashi Asada, Masaki Imagawa, Mikio Shoji, Susumu Higuchi, Katsuya Urakami, Akiyoshi Kakita, Hitoshi Takahashi, Tamao Tsukie, Shinichi Toyabe, Kohei Akazawa, Ichiro Kanazawa, Yasuo Ihara.   

Abstract

The apolipoprotein E (APOE) gene has been consistently shown to be a major genetic risk factor; however, all cases of Alzheimer's disease (AD) cannot be attributed to the epsilon4 variant of APOE, because about half of AD patients have the APOE-epsilon3*3 genotype. To identify an additional genetic risk factor(s), we performed large-scale single nucleotide polymorphism (SNP)-based association analysis of 1526 late-onset AD patients and 1666 control subjects in a Japanese population. We prepared two independent sets consisting of exploratory and validation samples, respectively, with only the APOE-epsilon3*3 genotype, and first carried out genotyping for the exploratory set with 1206 SNPs in the region between 60 and 107 Mb on chromosome 10q that is implicated by linkage studies as containing an AD susceptibility locus. Thirty-five SNPs that showed significant values (P<0.01) were followed-up to detect any association with the validation samples. Finally, six SNPs exhibited replicated significant associations (P=0.000035-0.00048) on meta-analysis of both sets. These SNPs were clustered in a locus spanning 220 kb at genomic position 101 Mb, and three of the six SNPs were located in the dynamin-binding protein (DNMBP) gene. Quantitative real-time RT-PCR analysis demonstrated that neuropathologically confirmed AD brains exhibit a significant reduction of DNMBP mRNA compared with age-matched ones (P<0.0169). Thus, we confirmed the association of DNMBP with AD individuals with the APOE-epsilon3*3 genotype or lacking the epsilon4 allele, and DNMBP may be one of the susceptibility genes for AD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16740596     DOI: 10.1093/hmg/ddl142

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  28 in total

1.  BAR proteins in cancer and blood disorders.

Authors:  Yolande Chen; Jorie Aardema; Ashish Misra; Seth J Corey
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

2.  A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk.

Authors:  Ute Dreses-Werringloer; Jean-Charles Lambert; Valérie Vingtdeux; Haitian Zhao; Horia Vais; Adam Siebert; Ankit Jain; Jeremy Koppel; Anne Rovelet-Lecrux; Didier Hannequin; Florence Pasquier; Daniela Galimberti; Elio Scarpini; David Mann; Corinne Lendon; Dominique Campion; Philippe Amouyel; Peter Davies; J Kevin Foskett; Fabien Campagne; Philippe Marambaud
Journal:  Cell       Date:  2008-06-27       Impact factor: 41.582

3.  Microarray analysis of hepatic gene expression in juvenile Japanese flounder Paralichthys olivaceus fed diets supplemented with fish or vegetable oils.

Authors:  Ubonrat Limtipsuntorn; Yutaka Haga; Hidehiro Kondo; Ikuo Hirono; Shuichi Satoh
Journal:  Mar Biotechnol (NY)       Date:  2013-09-20       Impact factor: 3.619

4.  The molecular genetics of sirtuins: association with human longevity and age-related diseases.

Authors:  Letizia Polito; Patrick G Kehoe; Gianluigi Forloni; Diego Albani
Journal:  Int J Mol Epidemiol Genet       Date:  2010-06-20

5.  GAB2 is not associated with late-onset Alzheimer's disease in Japanese.

Authors:  Akinori Miyashita; Hiroyuki Arai; Takashi Asada; Masaki Imagawa; Mikio Shoji; Susumu Higuchi; Katsuya Urakami; Shinichi Toyabe; Kohei Akazawa; Ichiro Kanazawa; Yasuo Ihara; Ryozo Kuwano
Journal:  Eur J Hum Genet       Date:  2008-10-15       Impact factor: 4.246

Review 6.  Current status on Alzheimer disease molecular genetics: from past, to present, to future.

Authors:  Karolien Bettens; Kristel Sleegers; Christine Van Broeckhoven
Journal:  Hum Mol Genet       Date:  2010-04-13       Impact factor: 6.150

7.  Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set.

Authors:  Winnie S Liang; Travis Dunckley; Thomas G Beach; Andrew Grover; Diego Mastroeni; Keri Ramsey; Richard J Caselli; Walter A Kukull; Daniel McKeel; John C Morris; Christine M Hulette; Donald Schmechel; Eric M Reiman; Joseph Rogers; Dietrich A Stephan
Journal:  Physiol Genomics       Date:  2008-02-12       Impact factor: 3.107

8.  Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology.

Authors:  Winnie S Liang; Travis Dunckley; Thomas G Beach; Andrew Grover; Diego Mastroeni; Keri Ramsey; Richard J Caselli; Walter A Kukull; Daniel McKeel; John C Morris; Christine M Hulette; Donald Schmechel; Eric M Reiman; Joseph Rogers; Dietrich A Stephan
Journal:  Neurobiol Aging       Date:  2008-06-24       Impact factor: 4.673

9.  Dynamin 2 gene is a novel susceptibility gene for late-onset Alzheimer disease in non-APOE-epsilon4 carriers.

Authors:  Nuripa Jenishbekovna Aidaralieva; Kouzin Kamino; Ryo Kimura; Mitsuko Yamamoto; Takeshi Morihara; Hiroaki Kazui; Ryota Hashimoto; Toshihisa Tanaka; Takashi Kudo; Tomoyuki Kida; Jun-Ichiro Okuda; Takeshi Uema; Hidehisa Yamagata; Tetsuro Miki; Hiroyasu Akatsu; Kenji Kosaka; Masatoshi Takeda
Journal:  J Hum Genet       Date:  2008-01-31       Impact factor: 3.172

10.  Isolation and characterization of patient-derived, toxic, high mass amyloid beta-protein (Abeta) assembly from Alzheimer disease brains.

Authors:  Akihiko Noguchi; Satoko Matsumura; Mari Dezawa; Mari Tada; Masako Yanazawa; Akane Ito; Manami Akioka; Satoru Kikuchi; Michio Sato; Shouji Ideno; Munehiro Noda; Atsushi Fukunari; Shin-ichi Muramatsu; Yutaka Itokazu; Kazuki Sato; Hitoshi Takahashi; David B Teplow; Yo-ichi Nabeshima; Akiyoshi Kakita; Kazutomo Imahori; Minako Hoshi
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.